Self-assembly of antibodies by chemical induction.
作者信息
Li Qing, Hapka David, Chen Hua, Vallera Daniel A, Wagner Carston R
机构信息
Department of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA.
出版信息
Angew Chem Int Ed Engl. 2008;47(52):10179-82. doi: 10.1002/anie.200803507.
Abstract
摘要
相似文献
1
Self-assembly of antibodies by chemical induction.
Angew Chem Int Ed Engl. 2008;47(52):10179-82. doi: 10.1002/anie.200803507.
2
[Development of recombinant scFv-antibodies against diphtheria toxin using phage display system].
Ukr Biokhim Zh (1999). 2007 Sep-Oct;79(5):91-7.
3
The future of monoclonal antibody engineering.
Ann Hematol. 2001;80 Suppl 3:B127-9. doi: 10.1007/pl00022775.
4
Chemically self-assembled antibody nanostructures as potential drug carriers.
Mol Pharm. 2012 Nov 5;9(11):3218-27. doi: 10.1021/mp300303k. Epub 2012 Oct 16.
5
Structural correspondences between mouse and human immunoglobulin VH genes. Application to the humanization of mouse monoclonal antibodies.
Ann N Y Acad Sci. 1995 Sep 29;764:359-61. doi: 10.1111/j.1749-6632.1995.tb55847.x.
6
Cloning and sequencing of the VH and V kappa genes of an anti-CD3 monoclonal antibody, and construction of a mouse/human chimeric antibody.
J Biochem. 1996 Sep;120(3):657-62. doi: 10.1093/oxfordjournals.jbchem.a021462.
7
8
Programmable self-assembly of antibody-oligonucleotide conjugates as small molecule and protein carriers.
J Am Chem Soc. 2012 Feb 15;134(6):2895-7. doi: 10.1021/ja210894g. Epub 2012 Feb 1.
9
Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
Protein Expr Purif. 2005 Jun;41(2):341-8. doi: 10.1016/j.pep.2005.02.005.
10
Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig.
Int Immunol. 2000 Mar;12(3):305-12. doi: 10.1093/intimm/12.3.305.
引用本文的文献
1
Multivalent Fluorinated Nanorings for On-Cell F NMR.
Biomacromolecules. 2024 Feb 12;25(2):1330-1339. doi: 10.1021/acs.biomac.3c01391. Epub 2024 Jan 22.
2
Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation.
Blood Adv. 2020 Nov 10;4(21):5343-5356. doi: 10.1182/bloodadvances.2020002255.
3
Eradication of Established Tumors by Chemically Self-Assembled Nanoring Labeled T Cells.
ACS Nano. 2018 Jul 24;12(7):6563-6576. doi: 10.1021/acsnano.8b01308. Epub 2018 Jun 4.
4
Engineering Reversible Cell-Cell Interactions with Lipid Anchored Prosthetic Receptors.
Bioconjug Chem. 2018 Apr 18;29(4):1291-1301. doi: 10.1021/acs.bioconjchem.8b00058. Epub 2018 Mar 23.
5
In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures.
Mol Pharm. 2016 Jul 5;13(7):2193-203. doi: 10.1021/acs.molpharmaceut.6b00110. Epub 2016 Mar 29.
6
Site-Specific PEGylation of Therapeutic Proteins.
Int J Mol Sci. 2015 Oct 28;16(10):25831-64. doi: 10.3390/ijms161025831.
7
Simultaneous dual protein labeling using a triorthogonal reagent.
J Am Chem Soc. 2013 Nov 6;135(44):16388-96. doi: 10.1021/ja403813b. Epub 2013 Oct 17.
8
Targeted delivery of antisense oligonucleotides by chemically self-assembled nanostructures.
Mol Pharm. 2013 Sep 3;10(9):3514-8. doi: 10.1021/mp400164f. Epub 2013 Jul 30.
9
Chemically self-assembled antibody nanostructures as potential drug carriers.
Mol Pharm. 2012 Nov 5;9(11):3218-27. doi: 10.1021/mp300303k. Epub 2012 Oct 16.
10
Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.
ACS Chem Biol. 2012 Jul 20;7(7):1139-51. doi: 10.1021/cb300119g. Epub 2012 Jul 3.
本文引用的文献
1
Engineering antibodies for clinical applications.
Trends Biotechnol. 2007 Jul;25(7):307-16. doi: 10.1016/j.tibtech.2007.05.001. Epub 2007 May 21.
2
Chemically controlled self-assembly of protein nanorings.
J Am Chem Soc. 2006 Jun 14;128(23):7630-8. doi: 10.1021/ja060631e.
3
Radioimmunotherapy of CD22-expressing Daudi tumors in nude mice with a 90Y-labeled anti-CD22 monoclonal antibody.
Clin Cancer Res. 2005 Nov 1;11(21):7920-8. doi: 10.1158/1078-0432.CCR-05-0725.
4
Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.
Cancer Res. 2005 Jul 1;65(13):5907-16. doi: 10.1158/0008-5472.CAN-04-4472.
5
Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice.
Leuk Res. 2005 Mar;29(3):331-41. doi: 10.1016/j.leukres.2004.08.006.
6
Generation and production of engineered antibodies.
Mol Biotechnol. 2004 Jan;26(1):39-60. doi: 10.1385/MB:26:1:39.
7
Dihydrofolate reductase mutant with exceptional resistance to methotrexate but not to trimetrexate.
J Med Chem. 2003 Jul 3;46(14):2816-8. doi: 10.1021/jm034057i.
8
Designing protein dimerizers: the importance of ligand conformational equilibria.
J Am Chem Soc. 2003 Feb 12;125(6):1501-7. doi: 10.1021/ja026264y.
9
Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics.
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13481-6. doi: 10.1073/pnas.172501499. Epub 2002 Oct 1.
10
Antibody engineering.
Annu Rev Biomed Eng. 2000;2:339-76. doi: 10.1146/annurev.bioeng.2.1.339.
Zotero 插件